TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 35.66% |
| Q3 2025 | 3.36% |
| Q2 2025 | -8.28% |
| Q1 2025 | 4.70% |
| Q4 2024 | -19.81% |
| Q3 2024 | 5.60% |
| Q2 2024 | -5.04% |
| Q1 2024 | -53.68% |
| Q4 2023 | 14.71% |
| Q3 2023 | 4.36% |
| Q2 2023 | -6.57% |
| Q1 2023 | -20.51% |
| Q4 2022 | -15.25% |
| Q3 2022 | -7.60% |
| Q2 2022 | 6.55% |
| Q1 2022 | -13.77% |
| Q4 2021 | 10.35% |
| Q3 2021 | -48.39% |
| Q2 2021 | -34.91% |
| Q1 2021 | -1.34% |
| Q4 2020 | -8.88% |
| Q3 2020 | -27.74% |
| Q2 2020 | -1.37% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |